Zantac / Ranitidine (NDMA Cancer) Lawsuit in Connecticut

Time limits apply in Connecticut. Find out if you still qualify.

Free Case Review

Start Your Free Review

Answer 2-3 quick questions to review your potential case.

Researched By
People's Justice Research Team

Verified against court records, regulatory records, and peer-reviewed research.

Last reviewed: March 2, 2026How we research

Last reviewed against primary sources: March 2, 2026

Statute of Limitations

Connecticut imposes a 2-year statute of limitations for product liability and personal injury claims (C.G.S. § 52-577a, § 52-584). Connecticut courts apply a reliability-based expert admissibility standard under Conn. Code Evid. § 7-2, similar to Daubert. The discovery rule applies to latent pharmaceutical injuries. Connecticut's dense pharmaceutical corridor history creates a significant claimant population with Zantac prescription histories.

2 years from date of cancer diagnosis discovery (Daubert-like expert standard)

Connecticut Data

Exposure in Connecticut

Source: U.S. Census Bureau 2024

Source: Delaware Superior Court 2025

Medical Resources

Clinics & Specialists in Connecticut

Yale Cancer Center / Smilow Cancer Hospital

Hartford HealthCare Cancer Institute